Browsing: Applications

Northwestern Medicine and Techstars have opened applications for the third class of their Healthcare Accelerator, inviting six health tech startups to join a three-month program in Chicago starting March 2027

CommonSpirit Health has opened grant applications for local nonprofits operating in its Mountain Region. 

Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two Phase 3 trials showing the treatment delivered substantial results

Healthy Weight for You (H-WFU) is a free, six-month weight management program offered by Wake Forest University’s Healthy Exercise and Lifestyle ProgramS (HELPS) exclusively for full-time, permanent employees. Designed for individuals who want to lose weight but are unsure where to begin, this medically directed and professionally supervised program goes beyond traditional lifestyle changes with…

Wake Forest’s Healthy Exercise and Lifestyle ProgramS (HELPS) is now accepting applications for the Fall 2026 Heart Health Program (HHP)

Anthropic is expanding its AI for Science programme with a dedicated funding initiative aimed at one of medicine’s most difficult challenges: rare genetic diseases. The AI company is inviting researchers and early-stage biotechnology firms to apply for grants that provide up to $50,000 in Claude API credits over six months, hoping to encourage new approaches…

Applications are now open for the Africa Health Collaborative (AHC) Research Fund 2026, an initiative supporting collaborative research led by Early Career Researchers (ECRs) from AHC member institutions. The fund aims to strengthen research capacity, foster international collaboration, and generate evidence that improves Health Human Reacross Sub-Saharan Africa

Cy-Fair ISD Nutrition Services’ online application for students’ free and reduced-priced breakfast and lunch eligibility for the 2026-27 school year opened July 13 and will stay open for the school year’s entirety, staff confirmed

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below

–  ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting three validated targets of amylin receptor, GLP-1R and GIPR